Dong-A ST has begun to develop a new improved drug avoiding the patent of Viread

As Dong-A ST has acquired approval to conduct a clinical study for a new improved drug of the blockbuster hepatitis B treatment, Viread(generic name: tenofovir) and started its product development.

The Ministry of Food and Drug Safety has approved a Phase 1 clinical study to directly compare a Dong-A ST’s hepatitis B drug, ‘DA-2802,’ with Viread 300mg in pharmacokinetic characteristic and drug...